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Brief Definitive Report
SERUM-MEDIATED
INHIBITION OF GRAFT-VS .-HOST REACTION
(From the Institute of Cancer Research Royal Cancer Hospital, TheRoyal Marsden Hospital, Sutton,
Surrey, England)
When parental type lymphoid cells are injected into F1 hybrid animals there is
usually a severe graft-vs.-host reaction (GVHR). It has been shown that a
proportion of animals will survive the acute episode, depending on the numberof
cells injected and the strain combination used, and that these animals are then
tolerant to a second challenge by parental type cells (1). We have previously
shown that this tolerance could be transferred from GVH-recovered rats to
normal rats by cross-circulation or parabiosis (2). X or /0 irradiation of the
transfused blood to doses of 1,000 rad did not inhibit the transfer of tolerance,
indicating that serum factors were responsible for mediating this phenomenon.
Initial attempts to transfer this tolerance by serum alone proved unsuccessful (2,
3), probably because insufficient amounts of serum were transferred.
The following experiments were designed to elucidate the role of serum factors
from rats undergoing or recovering from a GVHR using the relatively more
sensitive technique of local GVHR (4).
Materials and Methods
Rats.
￿
Youngadult rats from our own stock of highly inbred Marshall and August strain rats and
their F, hybrids were used.
Cell Suspensions.
￿
Spleen and lymph node tissues were diced with scissors andpressed througha
steel sieve (Mesh No. 100; Endecotts Test Sieves Ltd.) . The cells were washed in tissue culture
Medium 199, countedin ahemocytometer, and diluted to the required concentration . Theirviability,
as judged by trypan blue exclusion was about 90%.
GVH Reaction.
￿
Systemic GVHR was produced by intraperitoneal inoculation of 100-150 x 106
Marshall spleen cells. The degree of severity of the reaction was assessed on the scale described
previously (5). A local GVHR was produced by the technique of Elkins (4). In brief, this consisted of
inoculating 50 x 106 Marshall spleen or lymph node cells under thekidney capsule of hybrid rats of
thesame sex. Assessment of the severity of theGVHR wasmade on the 7th day after transplantation
from the relative weights of the kidneys and from the uptake of
['III] iododeoxyuridine (['25I]UdR;
The Radiochemical Center, Amersham, England; sp act, 1-6 mCi/mg), when 10 yCi were injected
intravenously (i.v.) 2 h before sacrifice . Both kidneys and the spleen were weighed, fixed in formal
saline for 24 h and then in several changes of 70% alcohol to remove the acid-soluble ' 25I (6), and
counted in an Autogamma spectrometer (Packard Ltd.) . This method has the additional advantage
that the tissues can be subsequently histologically examined .
The kidney indices for the weight and ['26I]UdR activity were calculated as follows:
( K; - K`
￿
treated/ (K, - K` ) control
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where the subscripts i and c refer to the weights, or activities of the injected and contralateral
(control) kidneys respectively . Similarly the spleen indices were calculated as:
treated/ S control
K, K)
where S is the spleen weight or activity.
Sera.
￿
Rats were bled under light ether anesthesia, 2-3 ml of blood being taken from the tail vein .
The sera were frozen at -10° C until required. Absorption of the sera and precipitation with 50%
ammonium sulphate were performed by standard techniques.
Lymphoid cells were suspended in Medium 199 at a concentration of 50 x 108/ml, and serum
(25-100 pl/10' cells) was added and incubated at 37°C for 60 min. The cells were then washed and
reconstituted to 50 x 10'/ml.
Results
When parental spleen cells are injected directly under the kidney capsule the
resulting GVHR is predominantly localized to that kidney and there is minimal
change in weight or ['251]UdR activity of the contralateral kidney . There is no
evidence of external symptoms at this time and for this dose of cells, but there is
some increase in weight and [1251]UdR activity in the spleen.
When 1 ml of serum from rats with acute systemic GVHR induced 4 wk
previously was injected i.v. into hybrid rats 1 h before transplantation of 50 x 106
Marshall spleen cells under the kidney capsule, there was a moderate depression
of 1251 uptake to 60% of controls (0 .1 < P < 0.05). However, when Marshall
spleen cells were preincubated with the serum at a concentration of 20-100 Al/10'
cells, there was a marked reduction of 1251 uptake to 24% of controls. (P < 0.01) .
There were corresponding but less pronounced changes in the splenic indices.
Lymph node cells were also inhibited by the serum, indicating a nonspleen-
specific factor.
Table I also shows that the globulin fraction obtained from serum by
precipitation with 50% ammonium sulphate can inhibit 1251 uptake. Absorption
of the serum by either parental strain spleen or kidney homogenates removed all
its inhibiting activity .
TABLE I
Effect of Preincubation of Parental Spleen or Lymph Node Cells with Serum from Normal and
GVHR-Recovered Animals
Cells Incubation
Kidney indices
Weight I'll uptake
Spleen indices
Weight I "I uptake
Spleen GVH-recovered serum (100 g1/ 121.1 t 14.9 24.1 t 0.9 76.0 t 3.8 44.1 t 14.1
10' cells)
Spleen GVH-recovered serum (20 ul/ 119.4 t 12.6 37.7 t 8.4 78.0 t 1.0 68.9 t 5.1
10' cells)
Spleen Normalserum (100 pl/10' cells) 102.6 t 11.9 103.1 t 8.7 95.6 t 2.9 89.6 t 1.1
Spleen Globulin fraction from GVH- 103.8 t 14.1 43.4 t 11 .0 82.4 t 4.2 54.9 t 5.7
recovered serum
Spleen Globulin fraction from normal 119.4 t 12.6 113.9 t 5.6 58.4 t 7.3 93.5 t 12.4
serum
Lymph node No preincubation 105.9 t 10.3 96.7 t 19.1 120.5 t 12.4 128.8 t 17.9
Lymph node GVH-recovered serum (100 till 37.1 t 8.7 25.3 t 8.3 93.2 t 1.7 120.1 t 19.5
10' cells)250
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It is to be noted that in the experiments with preincubation of the spleen cells
with serum from GVH-recovered animals, there is a discrepancy between the
kidney weight and 1251 uptake indices (121 and 24%, respectively), emphasizing
that enlargement of the kidney is not due to DNA-synthesizing lymphoid cells.
Gross changes could be observed : in the kidneys of rats transplanted with
Marshall spleen cells preincubated with GVHR serum there was accumulation of
hemorrhage under the kidney capsule. Histological examination of these kidneys
showed that whereas in the local GVHR there is massive infiltration of the kid-
neys with lymphoid cells, in the GVHR induced by spleen cells preincubated with
serum from GVH-recovered animals there is accumulation of hemorrhage with
minimal mononuclear cell infiltration .
To establish the rate of acquisition of these factors, hybrid rats were given the
standard inoculum of Marshall spleen cells to produce a systemic GVHR and
serum was taken 1 wk to 8 mo later. Normal Marshall cells were then incubated
with this serum and inoculated under the kidney capsule of fresh hybrid rats .
Considerable reduction in the '251 uptake was obtained with serum taken 1 wk
after induction of a systemic GVHR (Ki, 46.2 ~ 8.4). This reduction was still
observed with serum taken 8 mo after the initial induction of a systemic GVHR
(Ki, 45 .6 t 9.5) .
When normal Marshall spleen cells were injected under the kidney capsule of
rats undergoing a systemic GVHR, there was significant reduction in the kidney
and splenic indices only in rats 3 wk after induction of a GVHR, and was absent
in rats with GVHR of 6 wk to 8 mo duration, when superficial symptoms were no
longer obvious.
Discussion
These studies show that during the course of a GVHR, inhibitors appear in the
circulation within 1 wk and persist for up to 8 mo after inoculation of parental
cells. This phenomenon can be shown to occur by: (a) injection of serum from
GVH-recovered animals into F, hybrid rats before challenge with parental cells;
(b) direct challenge of GVH-recovered F, hybrid rats by parental cells systemi-
cally or locally under the kidney capsule; and (c) by preincubation of parental
cells with GVHR serum in vitro for 1 h before transfer to F, recipients. The last
technique appears to be the most sensitive index of inhibitory activity in such
sera, and indicates that the failure to demonstrate transfer of GVH inhibitory
activity by previous workers (2, 3) was due to insensitivity of the technique used,
or to the relatively inadequate amount of serum transferred.
It can also be seen in these studies that while there was a good correlation
between the weight and '251 uptake in kidneys injected with normal parental
cells, in animals which were given cells preincubated with inhibitor serum there
was gross enlargement of the kidney and poor 1251 uptake. Histological examina-
tion confirmed that this enlargement was largely due to accumulation of
hemorrhage with a relative reduction in the number of lymphoid cells.
The presence of antihost antibody activity in the sera of animals undergoing a
GVHR has been well documented . Kano et al. (7) found antibodies to C57BL/6
cells in the serum of (C57BL/6 x DBA)F, mice after multiple injections of DBA/2CAUCHI AND DAWSON
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spleen cells, and similarly, when C57BL/6 cells were injected in the hybrid mice,
an autoimmune hemolytic anemia developed where the antibody eluted from the
erythrocytes was shown to react with DBA/2 erythrocytes. Similarly, Gleich-
mann et al. (8) showed that immunoglobulin deposits in renal lesions had
allotypic markers of the donor, indicating that in chronic GVHR antibodies are
produced by the donor and directed against the host cells.
The above findings indicate that during the course ofa GVHR, factors appear
in the serum of the host which can react with parental-type cells. It has been
shown that during a GVHR the host cells are activated and capable of lysing
parental cells nonspecifically and that parental tumor cells exposed in vitro to
spleen cells from F, hybrid mice undergoing a GVHR had a markedly decreased
ability to grow in syngeneic recipients (9). Our findings would indicate that
similar reactivity against parental cells can be demonstrated in the serum of
animals recovering from GVH disease. In this respect these factors are different
from anti-idiotype antibodies which have recently been described by McKeam
and colleagues (10, 11) in hybrid rats undergoing a GVHR.
Summary
Rats recovering from a systemic graft-vs.-host reaction (GVHR) possess fac-
tors in the serum which can inhibit the production ofa local GVHR. After incuba-
tion in vitro for 1 h at 37°C these factors reduce the GVH-producing potential of
parental spleen or lymph node cells to 24% of control cells treated with normal
serum. These factors appear within i wk after initiation of a systemic GVHR
and some residual activity persists for up to 8 mo. The serum activity was pres-
ent in the globulin fraction and was completely removed by absorption with
spleen, lymph node, or kidney homogenates from either parental strain rats.
These studies indicate that during the course of a systemic GVHR, serum
factors directed against the host appear in the circulation and tend to inhibit the
production offurther GVHR by a second challenge ofeither parental strain cells.
Received forpublication 30 December 1974.
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